BRIDGE DIAGNOSTICS

Pharmacogenomics allows providers, health systems, payers, and PBMs to assess the viability of Pharmacogenomics testing in their patient population. Our proprietary software system ingests patient medication regimen data and compares it to the drug-gene interaction tables outlined by CMS (Centers for Medicare & Medicaid Services) to identify potential risk and medical necessity of Pharmacogenomics testing for every patient in the data set... Improving patient outcomes and ensuring individualized care for each patient that we serve is at the center of what we do. Our success is measured by our ability to directly enhance patient care by providing useful and innovative solutions to physicians and ensuring they have the most accurate diagnostics available.

Also known as: Bridge Diagnostics LLC

Primary location: Aliso Viejo United States